Michael Brooks
President en EDESA BIOTECH, INC. .
Fortuna: 74 068 $ al 31/03/2024
Perfil
Michael Brooks is currently the President at Edesa Biotech, Inc. He previously worked as the Director of Business Development at Cipher Pharmaceuticals, Inc. from 2010 to 2015.
He also held positions at Edesa Biotech, Inc. (Old) and Edesa Biotech Research, Inc. In terms of education, Dr. Brooks holds an MBA from the Rotman School of Management and undergraduate and doctorate degrees from the University of Toronto.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EDESA BIOTECH, INC.
0.56% | 02/04/2024 | 17 669 ( 0.56% ) | 74 068 $ | 31/03/2024 |
Cargos activos de Michael Brooks
| Empresas | Cargo | Inicio |
|---|---|---|
| EDESA BIOTECH, INC. | President | 07/06/2019 |
Antiguos cargos conocidos de Michael Brooks.
| Empresas | Cargo | Fin |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/01/2015 |
| Edesa Biotech Research, Inc. | Corporate Officer/Principal | - |
Edesa Biotech, Inc. (Old)
 Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | President | - |
Formación de Michael Brooks.
| Rotman School of Management | Masters Business Admin |
| University of Toronto | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| EDESA BIOTECH, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Health Technology |
| Edesa Biotech Research, Inc. |
- Bolsa de valores
- Insiders
- Michael Brooks
